
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma—A randomized phase II trial
Keywords: جمسیتابین; Non-small cell lung carcinoma; Chemotherapy; Epirubicin; Cisplatin; Gemcitabine; Expression of excision repair cross-complementing group 1 (ERCC1); Topoisomerase IIα (TopoIIα)